Menu Close

Agenda

Agenda

Click here for the full agenda in PDF format.

Selected scientific sessions (based on speakers’ consent) will be recorded and posted on the ILC symposium website after the end of the Symposium (similar to what was done for prior ILC Symposia). It will be available for free, and no registration is required to watch the recorded sessions.

Keynote Speakers

Cathrin Brisken, M.D., Ph. D.
Cathrin Brisken, MD, PhD
Swiss Federal Institute of Technology Lausanne (EFPL), Switzerland, Inst. of Cancer Research, London, UK
Stuart Schnitt, MD
Dana-Farber Cancer Institute,
Boston, MA, USA 

Confirmed Speakers & Chairs

Rohit Bhargava, MD
UPMC, Magee-Womens Hospital, Pittsburgh, PA, USA
Val Brunton, Ph.D.
Val Brunton, PhD
University of Edinburgh, Scotland
Amy Clark, MD, MSCE
Penn Medicine, Philadelphia, PA, USA
Giovanni Corso, M.D., Ph.D.
Giovanni Corso, MD, PhD
European Institute of Oncology, University of Milan, Italy
Matt Covington, M.D.
Matt Covington, MD
University of Utah,
Salt Lake City, UT, USA
Massimo Cristofanilli, M.D., FACP
Massimo Cristofanilli, MD, FACP
Weill Cornell Med./New York-Presbyterian Hosp., NY, USA
Nancy Davidson, M.D.
Nancy Davidson, MD
Fred Hutchinson Cancer Center, Seattle, WA, USA
Patrick Derksen, Ph.D.
Patrick Derksen, PhD
UMC Utrecht,
Netherlands 
Maxim De Schepper, MD, PhD
Katholieke Universiteit Leuven,
Leuven, Belgium
Christine Desmedt, PhD
Katholieke Universiteit Leuven,
Leuven, Belgium
Sean Egan, PhD
Hospital for Sick Children,
University of Toronto,
Toronto, ON
Julia Foldi, MD, PhD
University of Pittsburgh, UPMC
Pittsburgh, PA, USA
Siobhan Freeney
Lobular Breast Cancer Ireland
Arielle Hanker, Ph.D.
Arielle Hanker, PhD
University of Texas Southwestern,
Dallas, TX, USA
Jagmohan Hooda, PhD, MBA
University of Pittsburgh, Pittsburgh, PA, USA 
Rachel Jankowitz, MD
Penn Medicine, Philadelphia, PA, USA
Rinath Jeselsohn, M.D.
Rinath Jeselsohn, MD
Dana-Farber Cancer Institute,
Boston, USA    
Maria Margarete Karsten, M.D., Ph.D.
Maria Margarete Karsten, MD, PhD
Charité-Universitätsmedizin, Berlin, Germany
Thijs Koorman, Ph.D.
Thijs Koorman, PhD
UMC Utrecht,
Netherlands
Adrian Lee, Ph.D.
Adrian Lee, PhD
Institute for Precision Medicine, University of Pittsburgh & UPMC, Pittsburgh, PA, USA
Hannah Linden, MD, FACP
Fred Hutch Cancer Center, University of Washington, Seattle, WA, USA
Diane Mapes
Fred Hutchinson Cancer Center,
Seattle, WA, USA
Priscilla McAuliffe, MD, PhD
University of Pittsburgh, UPMC
Pittsburgh, PA, USA
Otto Metzger, M.D.
Otto Metzger, MD
Dana-Farber Cancer Institute,
Boston, MA, USA
 
Jason Mouabbi, M.D.
Jason Mouabbi, MD
University of Texas MD Anderson Cancer Center,
Houston, TX, USA
Rita Mukhtar, MD
University of California San Francisco, San Francisco, CA
Steffi Oesterreich, PhD
UPMC Hillman Cancer Center; Magee-Womens Research Institute, Pittsburgh, PA, USA
Lori Petitti
Independent ILC advocate; Breast Cancer Care & Research Fund (BCCRF)
Jorge Reis-Filho, M.D., Ph.D.
Jorge Reis-Filho, MD, PhD
Memorial Sloan Kettering Cancer Center, NY, USA
 
Rebecca Riggins, PhD
Georgetown University,
Washington, DC, USA
Matt Sikora, Ph.D.
Matt Sikora, PhD
University of Colorado Denver, Anschutz Medical Campus,
Denver, CO, USA
Ethan Sokol, Ph.D.
Ethan Sokol, PhD
Foundation Medicine,
Boston, USA
Claire Turner
Lobular Breast Cancer UK (LBCUK)
Gary Ulaner, M.D.
Gary Ulaner, MD
Hoag Family Cancer Institute, University of Southern, California, USA 
Karen Van Baelen, M.D.
Karen Van Baelen, MD
Katholieke Universiteit Leuven,
Leuven, Belgium
Vincent Vandecaveye, MD, PhD
University Hospitals Leuven,
Leuven, Belgium
Damir Vareslija, Ph.D.
Damir Varešlija, PhD
Royal College of Surgeons in Ireland (RCSI),
Dublin, Ireland
Anne Vincent-Salomon, MD, PhD
Institut Curie, Paris, France
Britta Weigelt, Ph.D.
Britta Weigelt, PhD
Memorial Sloan Kettering Cancer Center,
NYC, NY, USA 
Yosef Yarden, Ph.D.
Yossi Yarden, PhD
Dwek Inst. for Cancer Therapy Research, Weizmann Institute of Science, Rehovot, Israel